Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

On May 13, 2025 Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) therapeutics, reported that company management will participate in the below investor conferences (Press release, Cidara Therapeutics, MAY 13, 2025, View Source [SID1234652960]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: RBC Global Healthcare Conference
Date: Wednesday, May 21, 2025
Time: 10:00 AM ET

Event: Jefferies Global Healthcare Conference
Date: Wednesday, June 4, 2025
Time: 11:40 AM ET

The live webcast for the presentations can be accessed in the Investors section on the Company’s website at View Source Replays of the presentations will be available for at least 30 days.

Cidara will also participate in one-on-one investor meetings during these events.